Gretchen Adkins, MD
Obstetrics & Gynecology · Greensboro, NCNPI 1366599763
Payments from drug & device makers
Across 240 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$701
- Mayne Pharma Commercial LLC$488
- Astellas Pharma US Inc$329
- Evofem Biosciences, Inc.$206
- Biogen$175
- Exeltis, USA Inc.$170
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $701 |
| Mayne Pharma Commercial LLC | 24 | $488 |
| Astellas Pharma US Inc | 28 | $329 |
| Evofem Biosciences, Inc. | 15 | $206 |
| Biogen | 7 | $175 |
| Exeltis, USA Inc. | 11 | $170 |
| Daiichi Sankyo Inc. | 9 | $164 |
| Organon | 11 | $150 |
| Myovant Sciences Inc. | 7 | $138 |
| Avion Pharmaceuticals | 8 | $134 |
| Sumitomo Pharma America, Inc. | 7 | $130 |
| Therapeuticsmd, Inc. | 9 | $125 |
| Bayer | 7 | $92 |
| Lilly USA, LLC | 6 | $89 |
| Pfizer | 6 | $86 |
| Shield Therapeutics Inc | 5 | $77 |
| Pacira Pharmaceuticals Incorporated | 3 | $61 |
| Agile Therapeutics, Inc. | 3 | $52 |
| Currax Pharmaceuticals LLC | 3 | $42 |
| Novo Nordisk | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Coopersurgical, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $27 |
| Mylan Pharmaceuticals Inc. | 2 | $27 |
| Vertical Pharmaceuticals, LLC | 2 | $26 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Merck | 2 | $24 |
| Exact Sciences | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Cepheid | 1 | $22 |
| Aspira Women's Health Inc | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Renovia Inc | 1 | $18 |
| Davol Inc. | 1 | $18 |
| Millicent US Inc | 1 | $17 |
| Lupin Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Mission Pharmacal Company | 1 | $12 |
| Meditrina | 1 | $9 |
How this compares
$3,881 in reported general payments places this provider in the 85th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 87 | $3,703 |
| DottiEstradiol | 17 | $2,477 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,833 |
| YuvafemEstradiol | 11 | $1,471 |
| Alendronate Sodium | 67 | $528 |
| ValacyclovirValacyclovir Hcl | 27 | $512 |
| Ibandronate Sodium | 21 | $511 |
| Clobetasol Propionate | 12 | $210 |
| Tri-SprintecNorgestimate-Ethinyl Estradiol | 13 | $93 |
| Escitalopram Oxalate | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Greensboro
- Mark AndersonGreensboro$455K
- Laura McKainWilmington$2.6M
- Robert ParkerWinston-Salem$2.1M
- Allison PuechlCharlotte$1.6M
- Jeffrey MichelsonNew Bern$1.2M
- Robert LittletonRaleigh$976K
- Donald HornerCharlotte$907K
- Rebecca Dunsmoor SuMorrisville$837K
- Ann CollinsRaleigh$701K
- Kathryn PattenHendersonville$550K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.